These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 61942)

  • 1. Serum alpha-foetoprotein: diagnostic significance in liver disease.
    Prakash C; Kumar R; Gupta RR; Lal MM; Mehrotra GC
    Indian J Pathol Microbiol; 1976 Jan; 19(1):49-55. PubMed ID: 61942
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnostic and prognostic importance of the alpha-fetoprotein test in liver cancer and cirrhosis].
    Khazanov AI; Gerasimov GM
    Klin Med (Mosk); 1986 Apr; 64(4):80-5. PubMed ID: 2425125
    [No Abstract]   [Full Text] [Related]  

  • 3. [Two patients with liver cirrhosis who presented with alpha-fetoprotein values diagnostic of hepatocarcinoma but without evidence of neoplasms].
    Cristani A; Borghi A; Cioni G; Vignoli A; Ventura E
    Recenti Prog Med; 1992 May; 83(5):286-7. PubMed ID: 1279760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of alpha-fetoprotein assay as a tumor marker].
    Endo Y; Iino S; Miyazaki J
    Nihon Rinsho; 1990 Feb; 48 Suppl():949-52. PubMed ID: 1693988
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatocellular carcinoma.
    Durand F; Buffet C; Pelletier G; Hagege H; Ink O; Etienne JP
    N Engl J Med; 1993 Jan; 328(1):64; author reply 65. PubMed ID: 7677950
    [No Abstract]   [Full Text] [Related]  

  • 6. 5'-Nucleotide phosphodiesterase isozyme-V in hepatocellular carcinoma and other liver diseases.
    Fujiyama S; Tsude K; Sakai M; Sato T
    Hepatogastroenterology; 1990 Oct; 37(5):469-73. PubMed ID: 1701410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Alpha-fetoprotein as a tumor marker].
    Yachi A; Suga M
    Nihon Rinsho; 1980 Dec; 38(12):4554-9. PubMed ID: 6166768
    [No Abstract]   [Full Text] [Related]  

  • 8. When is a tumor marker a laboratory test?
    Galen RS
    Ann Clin Lab Sci; 1977; 7(1):51-6. PubMed ID: 65149
    [No Abstract]   [Full Text] [Related]  

  • 9. [Nonspecific tumor markers in hepatocellular carcinoma].
    Stanciu L; Dumitraşcu D; Radu D; Badea R; Petcovici M; Ioniţă A; Szabo P; Pascu O
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(5):443-9. PubMed ID: 2473509
    [No Abstract]   [Full Text] [Related]  

  • 10. [The significance of the determination of AFP-isoform in the early diagnosis of hepatocellular carcinoma].
    Ishizuka H; Arakawa Y; Nakano E
    Rinsho Byori; 1992 Dec; 40(12):1265-73. PubMed ID: 1284914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of needle biopsy and alpha-foetoprotein detection in the diagnosis of primary hepatocellular carcinoma.
    Deshpande AD; Patil SD; Talib SH
    J Assoc Physicians India; 1981 Feb; 29(2):129-32. PubMed ID: 6167562
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical significance of serum ferritin determination for hepatocellular carcinoma.
    Nakano S; Kumada T; Sugiyama K; Watahiki H; Takeda I
    Am J Gastroenterol; 1984 Aug; 79(8):623-7. PubMed ID: 6205585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Imaging in the screening and diagnosis of hepatocellular carcinoma in cirrhosis liver in Tunisia. A series of 30 cases].
    Ben Hassine L; Daghfous MH; Mami A; Chammakhi-Jemli C; Zouaoui W; Saddoud W; Miaoui A; Kharrat J; Ghorbal A; Sehili-Briki S
    Tunis Med; 2007 May; 85(5):421-6. PubMed ID: 17657932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A clinical study of complements as a marker of a hepatocellular carcinoma].
    Takezaki E; Murakami S; Nishibayashi H; Kagawa K; Ohmori H
    Gan No Rinsho; 1990 Oct; 36(12):2119-22. PubMed ID: 1700167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum alpha-fetoprotein in chronic liver disease.
    Weisz G; Udvardy M; Dalmi L; Kulcsár A
    Acta Med Hung; 1983; 40(2-3):155-64. PubMed ID: 6199736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical aspects of hepatocellular carcinoma in man.
    Desai HN
    S Afr Med J; 1976 Sep; 50(41):1611-3. PubMed ID: 62408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis.
    Kuwahara T; Sakai T; Majima Y; Hirai K; Tanikawa K
    Hepatogastroenterology; 1993 Aug; 40(4):347-51. PubMed ID: 7691701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Focus on a new assay of fucosylated alpha-fetoprotein and evaluation in the biological diagnosis of hepatocellular carcinoma in cirrhosis].
    Denis I; Beaudonnet A; Pichot J; Roubille M; Gelineau M
    Ann Biol Clin (Paris); 2000; 58(1):85-90. PubMed ID: 10673618
    [No Abstract]   [Full Text] [Related]  

  • 19. Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis.
    Hong WS; Hong SI; Park SY; Son Y; Lee YS; Chung YH; Yang SK; Suh DJ; Min YI
    Anticancer Res; 1995; 15(6B):2777-80. PubMed ID: 8669863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum arginase activity in patients with liver cirrhosis and hepatocellular carcinoma].
    Chrzanowska A; Mielczarek-Puta M; Skwarek A; Krawczyk M; Barańczyk-Kuźma A
    Wiad Lek; 2007; 60(5-6):215-8. PubMed ID: 17966882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.